MedTrace Logo

Prospective Registry of Histotripsy for Soft Tissue Tumors

NCT07470008 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 200

Last updated 2026-03-17

No results posted yet for this study

Summary

Histotripsy is a treatment that uses focused ultrasound waves to break down tissue without surgery. The ultrasound waves meet at a specific spot and turn the tissue into liquid. This study is a prospective observational registry of participants receiving histotripsy. The goal of this study is to gather information about the use of histotripsy to confirm it is safe and effective medical procedure.

Conditions

  • Soft Tissue Neoplasm
  • Soft Tissue Cancer
  • Soft Tissue Lesion

Interventions

OTHER

Medical Record Review

Data will be collected from the participants medical records.

Sponsors & Collaborators

Principal Investigators

  • Ryan Lokken, MD · University of California, San Francisco

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2026-01-29
Primary Completion
2030-08-08
Completion
2031-08-08

Countries

  • United States

Study Locations

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07470008 on ClinicalTrials.gov